Elastomeric Infusion Pump Market Global Report 2026

The elastomeric infusion pump market size has grown strongly in recent years. It will grow from $1.47 billion in 2025 to $1.58 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases requiring long-term infusion therapy, growth in hospital-based intravenous treatment procedures, rising adoption of disposable medical devices for infection control, expansion of oncology and pain management treatments, increasing demand for cost-effective drug delivery systems in healthcare facilities.

The elastomeric infusion pump market size is expected to see strong growth in the next few years. It will grow to $2.11 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to growing shift toward home healthcare and outpatient infusion therapy, increasing demand for patient-centric and portable drug delivery systems, rising focus on reducing hospital stay duration and healthcare costs, expansion of personalized medicine and targeted drug delivery, increasing adoption of minimally invasive and controlled infusion technologies. Major trends in the forecast period include increasing adoption of smart drug delivery monitoring systems integrated with patient data platforms, rising demand for personalized infusion therapy solutions in oncology and pain management, growing use of biodegradable and eco-friendly elastomeric pump materials, increasing preference for home-based infusion therapies supported by portable drug delivery devices, rising integration of cloud-based patient monitoring for infusion therapy adherence tracking.

The increasing prevalence of chronic pain conditions is expected to drive the growth of the elastomeric infusion pump market in the coming years. Chronic pain conditions are disorders characterized by persistent or recurrent pain lasting more than three months, often affecting daily functioning and overall quality of life. The rising incidence of these conditions is largely driven by the growing aging population, as older individuals are more susceptible to long-term pain associated with age-related musculoskeletal and neurological disorders. Elastomeric infusion pumps support the management of chronic pain conditions by enabling the continuous delivery of controlled doses of analgesic medication, thereby improving sustained pain relief and patient convenience. For example, in February 2025, according to Arthritis Australia, an Australia-based nonprofit organization, approximately 5.39 million Australians are expected to be living with arthritis, representing a 31% increase since 2025. Therefore, the rising prevalence of chronic pain conditions is driving the growth of the elastomeric infusion pump market.

The growing demand for home-based and ambulatory healthcare services is expected to drive the growth of the elastomeric infusion pump market in the coming years. Home-based and ambulatory healthcare services refer to medical services delivered outside inpatient hospital settings, including care provided at home and outpatient procedures that do not require hospital admission. The rising demand for these services is primarily driven by the need for cost-effective healthcare solutions, as they help reduce hospital stays, lower treatment expenses, and offer convenient care in home or outpatient environments. Elastomeric infusion pumps support home-based and ambulatory healthcare services by enabling portable and continuous medication delivery outside hospital settings, allowing patients to receive effective treatment while maintaining mobility and minimizing hospital visits. For example, in November 2023, according to the Department of Health and Aged Care, an Australia-based central government body, as of 2023, 277,612 individuals had access to a Home Care Package (HCP), representing a 17% increase (40,684 more people) compared to 2022, when 236,928 individuals had access. Therefore, the increasing demand for home-based and ambulatory healthcare services is driving the growth of the elastomeric infusion pump market.

The rising healthcare expenditure is expected to drive the growth of the elastomeric infusion pump market in the coming years. Healthcare expenditure refers to the total financial resources spent by individuals, organizations, or governments on the prevention, treatment, and management of health conditions. Healthcare spending is increasing due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often involve higher costs, thereby raising overall healthcare spending. Rising healthcare expenditure supports the growth of elastomeric infusion pumps by enabling greater investment in advanced and cost-effective drug delivery systems for hospital, ambulatory, and home-based care settings. For example, in April 2025, according to the Office for National Statistics, a UK-based independent producer of official statistics, healthcare spending in the UK reached approximately $370.71 billion (£317 billion) in 2024, reflecting a 6.5% nominal increase compared to 2023. Therefore, the rising healthcare expenditure is driving the growth of the elastomeric infusion pump market.

Major companies operating in the elastomeric infusion pump market are Baxter International Inc; B. Braun Melsungen AG; Fresenius Kabi AG; Avanos Medical Inc.; Nipro Corporation; ICU Medical Inc; Vygon Group; Leventon S.A.U.; Ace Medical Co. Ltd.; Pfm Medical AG; Daiken Medical Co. Ltd.; Woo Young Medical Co. Ltd.; Promecon Medical GmbH And Co. KG; Epic Medical Pte Ltd.; Spirit Medical Ltd.; Heka s.r.l.; Mais India; S&S Med Co. Ltd.; Terumo Corporation; Medline Industries.

North America was the largest region in the elastomeric infusion pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the elastomeric infusion pump market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the elastomeric infusion pump market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

An elastomeric infusion pump market consists of sales of multi-day infusion pumps, ambulatory infusion pumps, and disposable infusion pumps. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The elastomeric infusion pump market research report is one of a series of new reports that provides elastomeric infusion pump market statistics, including elastomeric infusion pump industry global market size, regional shares, competitors with a elastomeric infusion pump market share, detailed elastomeric infusion pump market segments, market trends and opportunities, and any further data you may need to thrive in the elastomeric infusion pump industry. This elastomeric infusion pump market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.